LFM A13

LFM A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK).

62004-35-7

2-Cyano-N- (2,5-dibromophenyl) -3-hydroxy-2-butenamide

41116105

Inhibitor

Synthetic

Cell Signaling | Cancer | Apoptosis | Cancer Growth Inhibitors | Tyrosine Kinase Inhibitors

≥97% (TLC)

0.025

Yellow solid

Soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml)

C11H8Br2N2O2

360

Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

1. Vassilev A., Ozer Z., Navara C., Mahajan S., & Uckun F.M. (1999). J. Biol. Chem. 274(3): 1646–1656.